All-Cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis. Implications for the Design and Execution of Clinical Trials

DOI Web Site 3 Citations

Talmadge E. King

University of California, San Francisco, California
Carlo Albera

University of Turin, Turin, Italy
Williamson Z. Bradford

InterMune Inc., Brisbane, California
Ulrich Costabel

Ruhrlandklinik, Essen, Germany
Roland M. du Bois

Imperial College, London, United Kingdom
Jonathan A. Leff

InterMune Inc., Brisbane, California
Steven D. Nathan

Inova Fairfax Hospital, Falls Church, Virginia
Steven A. Sahn

Medical University of South Carolina, Charleston, South Carolina
Dominique Valeyre

Assistance Publique-Hôpitaux de Paris, Avicenne University Hospital, Bobigny, France; and
Paul W. Noble

Cedars Sinai Medical Center, Los Angeles, California

Journal

American Journal of Respiratory and Critical Care Medicine

American Journal of Respiratory and Critical Care Medicine 189 (7), 825-831, 2014-04-01

American Thoracic Society

Back to top